We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
As with any medicine, the MHRA will keep the safety and effectiveness of rilzabrutinib under close review.
Patients will benefit from more services and treatments from their community pharmacy, as part of a new deal.
First published during the 2024 to 2026 Starmer Labour government
Patients taking Crescent Pharma Limited Ramipril 2.5mg capsules are advised to check their packaging for batch number GR155023 and contact their pharmacy if any blister strips inside are labelled as Ramipril 10mg.
Thousands of patients with painful joint and muscle conditions will receive employment support and treatment to tackle health-related economic inactivity.
UKHSA urges public to practise good food hygiene as new data shows persistently high levels of common gastrointestinal infections.
Jason is an experienced technology leader with over 25 years working in tech leadership and health informatics.
Essential advice on protecting your medicines during extreme heat and staying safe.
Government to introduce age verifications for sunbeds to protect young people from harm.
The first UKHSA One Health report tracks vector-borne diseases in England, with Lyme disease remaining the most common infection in 2025.
Support for Taiwan's meaningful participation in the World Health Organization and its observer participation in the World Health Assembly.
The MHRA launches public consultation on new framework that could lead to earlier licensing for therapies for up to 3.5 million people in the UK.
Proposed Rare Disease Therapies Framework introduces Investigational Marketing Authorisation and compressed development pathways – industry urged to respond
National memorial service held at St Paul's Cathedral to remember Infected Blood victims.
UK Statement for the Explanation of Vote on Lebanon. Delivered at the 79th World Health Assembly in Geneva.
UK National Statement for the 2026 World Heath Assembly as delivered by the UK's Permanent Representative to the WTO and UN, Kumar Iyer.
MHRA announces new programme of events and greater engagement with industries, researchers, local NHS and government in Wales.
Michelle Welsh MP appointed as the government's first Maternity Adviser.
Summary from the Global Partnership Conference satellite session in Geneva. Co-hosted by the UK and South Africa on 17 May 2026.
Innovation doesn’t wait for the rules to catch up. The question is whether we can build a system agile and flexible enough to keep pace.
As with any medicine, the MHRA will keep the safety and effectiveness of Vyjuvek under close review.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).